Natures Sunshine Products Inc (NATR) KPIs and segments
Close on Nov 17, 2026Market cap $181.76MP/E 10.2Yield –
KPIs & segments
Operating metrics and segments that drive Natures Sunshine Products's business
Natures Sunshine Products's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asia($M)6 | 53.0 | 52.2 | 55.7 | 64.7 | 52.7 | 48.7 | 56.3 | 55.3 | 50.0 | 46.2 | 47.8 | 52.2 | |
General health($M) | 21.5 | 18.4 | 20.2 | 24.8 | 20.4 | 18.3 | 23.6 | 22.6 | 19.1 | 16.0 | 20.2 | 16.9 | |
Cardiovascular($M) | 12.8 | 12.8 | 12.1 | 15.9 | 12.7 | 13.8 | 14.1 | 14.6 | 13.6 | 14.0 | 13.1 | 15.0 | |
Digestive($M) | 9.60 | 12.1 | 13.8 | 13.7 | 10.5 | 9.64 | 11.8 | 10.9 | 7.71 | 8.59 | 6.26 | 9.19 | |
Personal care($M) | 3.53 | 3.44 | 4.40 | 2.37 | 2.11 | 1.20 | 1.52 | 1.18 | 1.04 | 1.29 | 1.43 | 1.38 | |
Immunity($M) | 3.08 | 3.20 | 3.13 | 4.46 | 3.98 | 2.87 | 5.62 | 2.50 | 2.25 | 1.68 | 1.68 | 1.96 | |
Weight management($M) | 2.48 | 2.29 | 2.11 | 3.50 | 2.93 | 2.87 | 3.58 | 6.23 | 4.69 | 5.19 | 7.79 | ||
North America($M)6 | 36.0 | 38.3 | 37.4 | 36.2 | 35.0 | 35.0 | 35.1 | 33.6 | 33.6 | 36.5 | 35.7 | 34.8 | |
General health($M) | 16.2 | 17.2 | 14.7 | 16.2 | 15.7 | 15.6 | 12.8 | 15.3 | 15.0 | 16.4 | 16.0 | 16.3 | |
Digestive($M) | 10.1 | 10.7 | 14.2 | 9.41 | 9.25 | 8.93 | 13.0 | 8.58 | 8.56 | 9.17 | 8.56 | 8.58 | |
Cardiovascular($M) | 3.71 | 3.90 | 3.21 | 4.04 | 3.72 | 3.70 | 3.07 | 3.63 | 3.76 | 3.98 | 3.98 | 3.63 | |
Immunity($M) | 3.32 | 3.95 | 3.50 | 3.78 | 3.67 | 4.44 | 4.13 | 3.69 | 3.54 | 4.45 | 4.43 | 3.64 | |
Personal care($M) | 1.88 | 1.88 | 1.57 | 1.80 | 1.64 | 1.48 | 1.58 | 1.51 | 1.58 | 1.57 | 1.66 | 1.72 | |
Weight management($M) | 0.72 | 0.66 | 0.22 | 0.97 | 1.00 | 0.87 | 0.51 | 0.96 | 1.10 | 0.95 | 1.07 | 0.89 | |
Europe($M)6 | 22.7 | 26.4 | 25.2 | 22.1 | 21.7 | 24.1 | 21.3 | 19.6 | 21.6 | 22.3 | 19.7 | 18.8 | |
General health($M) | 9.59 | 11.6 | 10.4 | 9.27 | 9.61 | 10.5 | 8.10 | 9.19 | 9.53 | 9.80 | 8.89 | 8.03 | |
Digestive($M) | 6.51 | 6.87 | 6.81 | 5.79 | 5.63 | 6.37 | 7.21 | 3.68 | 5.95 | 5.91 | 4.96 | 5.09 | |
Cardiovascular($M) | 2.90 | 3.22 | 3.00 | 2.60 | 2.64 | 2.57 | 1.55 | 3.00 | 2.30 | 2.42 | 2.06 | 2.26 | |
Immunity($M) | 1.88 | 2.48 | 2.67 | 2.05 | 1.99 | 2.44 | 2.23 | 1.69 | 2.20 | 2.34 | 2.23 | 1.56 | |
Personal care($M) | 1.12 | 1.43 | 1.39 | 1.48 | 1.32 | 1.63 | 2.22 | 0.77 | 1.15 | 1.27 | 1.20 | 1.35 | |
Weight management($M) | 0.70 | 0.75 | 0.88 | 0.93 | 0.56 | 0.61 | 0.01 | 1.30 | 0.48 | 0.56 | 0.36 | 0.47 | |
Latin America and Other($M)6 | 5.34 | 5.99 | 5.51 | 5.28 | 5.37 | 5.46 | 5.45 | 6.08 | 5.40 | 5.95 | 5.73 | 5.42 | |
Digestive($M) | 2.52 | 2.80 | 2.69 | 2.51 | 2.50 | 2.58 | 2.63 | 2.85 | 2.49 | 2.75 | 2.66 | 2.56 | |
General health($M) | 1.58 | 1.83 | 1.66 | 1.57 | 1.66 | 1.58 | 1.53 | 1.75 | 1.56 | 1.57 | 1.57 | 1.48 | |
Immunity($M) | 0.45 | 0.52 | 0.42 | 0.46 | 0.45 | 0.52 | 0.51 | 0.59 | 0.59 | 0.72 | 0.68 | 0.61 | |
Cardiovascular($M) | 0.40 | 0.46 | 0.40 | 0.39 | 0.39 | 0.43 | 0.40 | 0.45 | 0.40 | 0.48 | 0.43 | 0.39 | |
Personal care($M) | 0.22 | 0.23 | 0.21 | 0.21 | 0.25 | 0.24 | 0.28 | 0.31 | 0.27 | 0.28 | 0.29 | 0.28 | |
Weight management($M) | 0.17 | 0.16 | 0.13 | 0.14 | 0.12 | 0.11 | 0.11 | 0.13 | 0.09 | 0.15 | 0.10 | 0.10 | |
General health($M) | 48.9 | 49.1 | 46.9 | 51.9 | 47.4 | 45.9 | 46.1 | 48.8 | 45.3 | 43.8 | |||
Digestive($M) | 28.7 | 32.5 | 37.6 | 31.4 | 27.9 | 27.5 | 34.6 | 26.0 | 24.7 | 26.4 | |||
Cardiovascular($M) | 19.8 | 20.3 | 18.7 | 23.0 | 19.5 | 20.5 | 19.1 | 21.6 | 20.1 | 20.9 | |||
Immunity($M) | 8.73 | 10.1 | 9.72 | 10.7 | 10.1 | 10.3 | 12.5 | 8.47 | 8.59 | 9.19 | |||
Personal care($M) | 6.76 | 6.98 | 7.57 | 5.85 | 5.31 | 4.55 | 5.60 | 3.76 | 4.04 | 4.41 | |||
Weight management($M) | 4.06 | 3.86 | 3.33 | 5.54 | 4.61 | 4.46 | 0.31 | 5.97 | 7.89 | 6.35 | |||
Other($M) | 39.4 | 47.6 | 42.9 | 39.8 | 52.1 | 9.46 | 38.1 | 40.2 | 49.9 | 49.2 | 49.4 | ||
United States($M) | 33.6 | 35.6 | 34.7 | 33.7 | 32.5 | 32.5 | 32.3 | 31.0 | 30.9 | 33.7 | 33.0 | 32.2 | |
Japan($M) | 18.2 | 12.4 | 14.2 | 17.7 | 13.2 | 11.0 | 11.8 | 13.3 | 9.69 | ||||
Taiwan($M) | 13.7 | 15.0 | 13.8 | 18.9 | 16.7 | 17.9 | 20.1 | 18.4 | 16.3 | 15.8 | 15.9 | 15.6 | |
South Korea($M) | 12.0 | 12.2 | 12.3 | 15.2 | 12.5 | 10.8 | 12.4 | 13.9 | 13.4 | 11.6 | 10.9 | 13.9 | |
Asia($M) | 8.34 | 10.5 | 8.41 | 13.1 | 10.3 | 8.35 | 8.55 | 10.4 | 8.39 | 6.82 | |||
North America($M) | 7.92 | 9.12 | 8.94 | 7.79 | 6.39 | 7.74 | 7.36 | 7.44 | 7.78 | 8.34 | |||
Europe($M) | 2.10 | 2.77 | 1.82 | 2.32 | 1.74 | 2.17 | 1.35 | 0.71 | 0.83 | 1.78 | |||
Latin America and Other($M) | 0.40 | 0.72 | 0.21 | 0.28 | 0.36 | 0.39 | 0.49 | 0.69 | -0.17 | 0.28 | |||
Asia($M) | 41.2 | 41.2 | 43.8 | 50.8 | 40.9 | 37.8 | 43.6 | 41.9 | 38.0 | 35.6 | |||
North America($M) | 25.0 | 25.9 | 24.7 | 24.2 | 22.8 | 23.5 | 23.2 | 22.8 | 23.2 | 24.3 | |||
Europe($M) | 16.4 | 19.0 | 17.6 | 15.6 | 15.4 | 17.0 | 14.7 | 12.9 | 14.3 | 15.1 | |||
Latin America and Other($M) | 3.55 | 3.86 | 3.66 | 3.41 | 3.25 | 3.42 | 3.52 | 4.09 | 3.44 | 3.92 | |||
Earlier reporting (last reported 2024)4 | |||||||||||||
Earlier reporting (last reported 2024)4 | |||||||||||||
42 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-06.
See a number that looks wrong?